Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Interview with Prof John Hooper about pancreatic cancer research
Community Conversations Prostate Cancer Foundation of Australia (PCFA) invites you to attend their free Community Conversations forum, to discuss the latest research and management of prostate cancer...Read more
CLIMB FOR CANCER 2017 - TEAM TRI It's time for Team TRI to unite once again, battling 810 stairs with the same determination we use to battle cancer every day. This year our TRI corporate team is...Read more
Melanoma research breakthrough gives hope to treatment A QUT-driven project has identified the way in which melanoma cells spread, opening up new pathways to treatment via drugs to ‘turn off...Read more
Toowoomba Chronicle "City digs deep and raises $51,000 for breast cancer" TRI based QUT researcher Dr Elouise Dray talked to The Chronicle this week after attending the MJH Advisory Colour...Read more
Targeted therapy in melanoma: From response to resistance Professor Kieran Smalley from the MOFFITT Cancer Centre in Tampa, Florida, will be visiting the TRI on the 18th October to deliver a featured...Read more
Does your Research Make a Difference? Translation of Sun Protection and UVR Risk Reduction Behaviour into Community Settings A/Prof Lois Loescher will present on models of research translational and...Read more
Simpson Lab FEatured on 10 News In a world first, Brisbane scientists have discovered a drug that could help treat an aggressive and advanced type of breast cancer > CLick to watch on You Tube...Read more
Amyloidosis News features Proteomics Facility Leukaemia Foundation's Amyloidosis Autumn 2016 newsletter features an article by Dorothy Loo from the TRI Proteomics Core Facility. The article looks...Read more
MAKING NEW AND UNEXPECTED DISCOVERIES IN THE SEARCH FOR CIS-REGULATORY MUTATIONS IN CANCER GENOMES Abstract Mutations that directly alter protein function have long been associated with cancer. Yet,...Read more
Cancer Seminar Series Join us for this interdisciplinary seminar series highlighting cutting edge clinical, translational, and basic research topics in cancer from our research partner institutes: UQ...Read more